Invention Grant
US08193349B2 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors
有权
4-苄基氨基-1-羧基 - 哌啶衍生物作为CETP抑制剂
- Patent Title: 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors
- Patent Title (中): 4-苄基氨基-1-羧基 - 哌啶衍生物作为CETP抑制剂
-
Application No.: US12265369Application Date: 2008-11-05
-
Publication No.: US08193349B2Publication Date: 2012-06-05
- Inventor: Muneto Mogi , Ken Yamada , Kayo Yasoshima , Toshio Kawanami , Ichiro Umemura , Yuki Iwaki , Hongbo Qin , Hidetomo Imase
- Applicant: Muneto Mogi , Ken Yamada , Kayo Yasoshima , Toshio Kawanami , Ichiro Umemura , Yuki Iwaki , Hongbo Qin , Hidetomo Imase
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Sophie Binet Cross
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D413/14
Abstract:
The present invention provides a compound of formula (I): wherein the variants R1, R2, R3, R4, R5, R6, R7 are as defined herein, and wherein said compound is an inhibitor of CETP, and thus can be employed for the treatment of a disorder or disease mediated by CETP or responsive to the inhibition of CETP.
Public/Granted literature
- US20090118287A1 ORGANIC COMPOUNDS Public/Granted day:2009-05-07
Information query
